Women with diabetes five times more prone to heart failure than normal women Hina Zahid19 Nov 2019 1:50 PM GMTSophia Antipolis: Patients with diabetes remain at significantly higher cardiovascular risk and out of the women are most affected by the vascular...
Edoxaban dual therapy, safe alternative after PCI in AF patients Medha Baranwal Baranwal11 Sep 2019 1:55 PM GMTParis, France: Dual therapy without aspirin (Edoxaban + a P2Y12 inhibitor) is non-inferior to standard triple therapy (oral anticoagulant, aspirin,...
Breakthrough device: New Ultrasound System for Pulmonary arterial hypertension patients Deepanjana Sarkar10 Sep 2019 2:00 PM GMTThe U.S Food and Drug Administration has granted breakthrough device designation to the SoniVie's Therapeutic Intra-Vascular Ultrasound (TIVUS) System...
Aspirin not recommended for healthy elderly: ESC 2019 Update Medha Baranwal Baranwal31 Aug 2019 11:56 AM GMTDaily low-dose aspirin cannot be recommended in healthy people over 70 – even in those at the greatest cardiovascular disease (CVD) risk, according to...
Exercise may improve cognitive function and memory in Heart failure: ESC Dr. Kamal Kant Kohli Kohli5 May 2019 3:30 AM GMTExercise may improve cognitive function and memory in Heart failure.According to research presented today at EuroHeartCare 2019, a scientific congress...
High BP patients have increased death risk if exposed to work stress and insomnia Dr. Kamal Kant Kohli Kohli30 April 2019 1:40 PM GMTHigh blood pressure patients if subjected to work stress and disturbed sleep are at higher risk of CVD death finds new research.Work stress and...
New ECG method developed that uses signals from ears Medha Baranwal Baranwal19 March 2019 2:58 PM GMTLisbon: In a study presented at the European Society of Cardiology (ESC) Congress, the researchers have developed a novel electrocardiogram (ECG)...
Male-pattern baldness and premature graying associated with risk of early heart disease Anjali Nimesh Nimesh30 Nov 2017 1:52 PM GMTMale-pattern baldness and premature greying are associated with a more than fivefold risk of heart disease before the age of 40 years, according to...
Cholesterol drug Anacetrapib cuts heart risk by 9 pct : NEJM Anjali Nimesh Nimesh2 Oct 2017 3:30 AM GMTA large study of Merck & Co Inc's experimental cholesterol drug anacetrapib found that it cut the risk of heart attack and death by a modest 9...
ESC updates Guidelines for peripheral artery disease Anjali Nimesh Nimesh19 Sep 2017 12:29 PM GMTEuropean Society of Cardiology (ESC) Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, developed in collaboration with the...
